The Food and Drug Administration (FDA) approved a weight-loss drug to help sleep apnea, becoming the first drug to treat the disorder affecting millions of Americans. On Friday, the federal agency ...

Although the new FDA green light doesn’t expand the number of people who may be eligible for the drug, since the sleep apnea approval is specifically for people with obesity, it could lead to ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...

The trials presented in the application for FDA approval of Enovid as an oral contraceptive were the largest drug trials ever run. In the trials, 897 women had taken 10,427 cycles of the Pill with ...

The FDA first approved Zepbound to treat obesity in November 2023. Its active ingredient, tirzepatide, was previously approved as Mounjaro to treat Type 2 diabetes and became popular as an off ...

Sleep apnea “occurs when a person’s upper airway becomes blocked, causing pauses in breathing during sleep,” per the FDA. “Today’s approval marks the first drug treatment option for ...

The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could be used for in adults and children 10 and up. The new drug ...

The move follows the FDA’s approval last month of a generic version of exenatide (Byetta, Amylin Pharmaceuticals). The FDA has prioritized these approvals to improve access to GLP-1 medications ...